临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2014年
20期
18-20
,共3页
鲁华%郭更新%刘爱翔%张萍%夏晗
魯華%郭更新%劉愛翔%張萍%夏晗
로화%곽경신%류애상%장평%하함
血液透析%动静脉内瘘%罂粟碱%低分子肝素
血液透析%動靜脈內瘺%罌粟堿%低分子肝素
혈액투석%동정맥내루%앵속감%저분자간소
Hematodialysis%Internal arteriovenous fistula%Papaverine%Low molecular heparin
目的:探讨罂粟碱联合低分子肝素钙在动静脉内瘘围手术期中的疗效观察,以提高动静脉内瘘的初期开放率及远期成熟率。方法选取2008年7月-2013年9月医院确诊为慢性肾衰竭尿毒症期(CKD5期)的患者296例。随机分成治疗组和对照组各148例。治疗组予盐酸罂粟碱局部注射,术后予盐酸罂粟碱肌内注射,并于术后联合低分子肝素钙皮下注射;对照组仅术中予温0.9%氯化钠溶液局部注射。2组术后均予双密达莫口服并予丹参注射液静点。结果296例手术成功273例,总内瘘初期开放率92.2%。其中治疗组142例,初期开放率95.8%;对照组131例,初期开放率88.5%。2组比较差异有统计学意义(P ﹤0.05)。初次手术成功的273例患者随访3个月,258例达到内瘘成熟,总成熟率94.5%。其中治疗组140例,成熟率98.6%;对照组118例,成熟率90.1%,2组比较差异有统计学意义(P ﹤0.05)。2组均未出现明显不良反应。结论罂粟碱联合低分子肝素钙在动静脉内瘘成形术围手术期中的应用能有效地缓解血管痉挛,预防血栓形成,提高手术成功率,提高内瘘初期放开率及远期成熟率。
目的:探討罌粟堿聯閤低分子肝素鈣在動靜脈內瘺圍手術期中的療效觀察,以提高動靜脈內瘺的初期開放率及遠期成熟率。方法選取2008年7月-2013年9月醫院確診為慢性腎衰竭尿毒癥期(CKD5期)的患者296例。隨機分成治療組和對照組各148例。治療組予鹽痠罌粟堿跼部註射,術後予鹽痠罌粟堿肌內註射,併于術後聯閤低分子肝素鈣皮下註射;對照組僅術中予溫0.9%氯化鈉溶液跼部註射。2組術後均予雙密達莫口服併予丹參註射液靜點。結果296例手術成功273例,總內瘺初期開放率92.2%。其中治療組142例,初期開放率95.8%;對照組131例,初期開放率88.5%。2組比較差異有統計學意義(P ﹤0.05)。初次手術成功的273例患者隨訪3箇月,258例達到內瘺成熟,總成熟率94.5%。其中治療組140例,成熟率98.6%;對照組118例,成熟率90.1%,2組比較差異有統計學意義(P ﹤0.05)。2組均未齣現明顯不良反應。結論罌粟堿聯閤低分子肝素鈣在動靜脈內瘺成形術圍手術期中的應用能有效地緩解血管痙攣,預防血栓形成,提高手術成功率,提高內瘺初期放開率及遠期成熟率。
목적:탐토앵속감연합저분자간소개재동정맥내루위수술기중적료효관찰,이제고동정맥내루적초기개방솔급원기성숙솔。방법선취2008년7월-2013년9월의원학진위만성신쇠갈뇨독증기(CKD5기)적환자296례。수궤분성치료조화대조조각148례。치료조여염산앵속감국부주사,술후여염산앵속감기내주사,병우술후연합저분자간소개피하주사;대조조부술중여온0.9%록화납용액국부주사。2조술후균여쌍밀체막구복병여단삼주사액정점。결과296례수술성공273례,총내루초기개방솔92.2%。기중치료조142례,초기개방솔95.8%;대조조131례,초기개방솔88.5%。2조비교차이유통계학의의(P ﹤0.05)。초차수술성공적273례환자수방3개월,258례체도내루성숙,총성숙솔94.5%。기중치료조140례,성숙솔98.6%;대조조118례,성숙솔90.1%,2조비교차이유통계학의의(P ﹤0.05)。2조균미출현명현불량반응。결론앵속감연합저분자간소개재동정맥내루성형술위수술기중적응용능유효지완해혈관경련,예방혈전형성,제고수술성공솔,제고내루초기방개솔급원기성숙솔。
Objective To explore the effect of pharmacal interventions in peroperative period of internal arteriove-nous fistula angioplasty,in order to improve the initial opening rate and the forward maturation rate. Methods 296 cases of patients diagnosed with chronic renal failure(uraemia stage V of chronic kidney dieases,CKD5 )in our hospital from July 2008 to September 2013 were selected and randomly divided into treatment group and control group,with 148 patients in each groups. Patients in treatment group were treated by local injection with papaverine hydrochloride during the operation,and then by intramuscular injection with papaverine hydrochloride. After that,low molecular weight heparin was given by subcutaneous injection was accompanied post-operation. while the patients in control group were treated by local injection with warm saline during the operation. All of the patients in both groups were treated with oral dipyridamole and danshen injection. Results 273 cases of patients received successful operation in all the 296 patients,with the overall initial opening rate of 92. 2% ,inclu-ding 142 cases in treatment group with initial opening rate of 95. 8% and 131 cases in control group with initial opening rate of 88. 5% ,and the differences were statistically significant(P ﹤ 0. 05). During the 3-month-follow-up,among 273 patients who received successful operations,mature internal arteriovenous fistula were seen in 258 patients,with the overall maturing rate of 94. 5% ,including 140 patients in treatment group with maturing rate of 98. 6% ,and 118 patients in control group with matu-ring rate of 90. 1% ,and the differences was also statistically significant(P ﹤ 0. 05). There were no significant side effects in both groups. Conclusion The application of papaverine and low molecular heprin in peroperative period of internal arteriove-nous fistula could effectively remit vasospasm,prevent thrombosis,improve the achievement ratio of operation,so as to improve the initial opening rate and the forward maturation rate.